Research Reports Highlight Q1FY27 Growth and Outlook for Apollo Hospitals and Max Healthcare
ICICI Securities, Prabhudas Lilladher, and Motilal Oswal released research reports on Apollo Hospitals and Max Healthcare Institute's Q1FY27 performance. Apollo Hospitals saw 22% revenue growth driven by new hospitals and improved occupancy, with a HOLD rating and target price of INR 8,500. Max Healthcare reported 15-15.3% revenue growth aided by bed capacity expansion and price hikes, with all three firms maintaining BUY ratings and target prices ranging from INR 1,150 to INR 1,410. Outlooks highlight ongoing hospital expansions and margin improvements amid some cost pressures.
First-hand measurement across 3 sources
We measured how 3 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is positive (68/100). Lens Score 28/100.
Outlets measured: moneycontrol, moneycontrol, moneycontrol. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (68–75/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
moneycontrol broke this story on 17 Aug, 05:47 am. Other outlets followed.